Bristol-Myers Squibb Company (BMY)
NYSE: BMY · Real-Time Price · USD
46.86
-1.66 (-3.42%)
At close: Jul 11, 2025, 4:00 PM
46.90
+0.04 (0.09%)
After-hours: Jul 11, 2025, 7:59 PM EDT

BMY Revenue

Bristol-Myers Squibb Company had revenue of $11.20B in the quarter ending March 31, 2025, a decrease of -5.60%. This brings the company's revenue in the last twelve months to $47.64B, up 4.62% year-over-year. In the year 2024, Bristol-Myers Squibb Company had annual revenue of $48.30B with 7.32% growth.

Revenue (ttm)
$47.64B
Revenue Growth
+4.62%
P/S Ratio
2.00
Revenue / Employee
$1,396,950
Employees
34,100
Market Cap
95.36B

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 48.30B 3.29B 7.32%
Dec 31, 2023 45.01B -1.15B -2.50%
Dec 31, 2022 46.16B -226.00M -0.49%
Dec 31, 2021 46.39B 3.87B 9.09%
Dec 31, 2020 42.52B 16.37B 62.62%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 63.92B
AbbVie 57.37B
AstraZeneca 54.98B
Novartis AG 53.22B
Eli Lilly and Company 49.00B
Novo Nordisk 43.92B
Revenue Rankings